HEPON

Registration number:P N000015/01
Pharmaceutical form:lyophilizate for solution for topical and external application.
Pharmacotherapeutic group:immunomodulatory agent
Dosage form:Lyophilizate for solution for topical and external application 1 mg, 2 mg. 1 mg, 2 mg of the medicinal product in vials. 1 mg, 2 mg of the medicinal product in ampoules.
Composition:Active substance: Treonyl-glutamyl-lysyl-lysyl-arginyl-arginyl-glutamyl-threonyl-valyl-glutamyl-arginyl-glutamyl-lysyl-glutamate (Hepon) 1 mg, 2 mg

HEPON produces an immunomodulating and antiviral effect.

Indications for use:: Within the combination therapy: treatment of mucosal and skin infections caused by Candida fungi; decrease of the inflammation degree (reddening, oedema, pruritus, burning, pain) on the mucosae and skin, dryness of mucosae. Prophylaxis of skin and mucous membranes candidiasis secondary to antibacterial treatment.
Method of administration and posology:: For topical, external application.
Before use, dissolve the medicinal product in water for injection (in case of external drug use, i.e. for skin treatment) or in 0.9 % sodium chloride solution (in case of topical drug use, i.e. for mucosae treatment).